NMPA has announced the results of the seventh batch of special review applications for innovative medical devices this year, with 10 innovative products approved for the special review process for innovative medical devices. The 10 products are from cardiovascular, orthopaedic, diabetes, imaging, tumor and other fields. Among them, cardiovascular remains a highland of innovation, with four products selected, including the transcatheter aortic valve system based on the heart, Xianjians nickel titanium alloy patent ductus arteriosus occluder, Minimally Invasive Investments nanosecond pulse electric field ablation system (Shanghai Shangyang Medical Technology Co., Ltd.), and Chenxing atrial septal defect shunt.